Introduction
The concept of an endogenous descending analgesia system was born of Reynolds' dramatic discovery that electric stimulation was capable of producing profound analgesia [40] . In Reynolds' study, rats failed to protest in response to a surgical laparotomy as long as a region in the dorsal midbrain, close to the periaqueductal gray (PAG), was electrically stimulated. Even as midbrain stimulation suppressed escape, the normal behavioral reaction to surgical incision, animals continued to startle in response to unexpected auditory or looming visual stimuli. This dichotomy is evidence for sensory suppression rather than motor immobilization. Reynolds' demonstration of stimulation-produced surgical analgesia was therefore viewed with great excitement as a potentially novel approach to treating patients with intractable pain. In short order, the search for ways to utilize this endogenous system for the betterment of pain patients was launched in multiple laboratories and clinics. Neurosurgeons tried, with some success, to provide pain relief to patients with intractable pain using stimulation in either the periaqueductal or periventricular gray [25, 26, 31, 45, 46] . The discovery several years later of endogenous opioid peptides and the distribution of these opioids within the brainstem regions implicated in endogenous analgesia led to the idea that morphine's efficacy derives from its ability to engage the endogenous analgesia system. Fueled by a concern for the tolerance and side effects caused by morphine, a search for compounds that specifically and cleanly engage endogenous analgesia pathways began. That quest, which has led to incremental improvements in pain management but has not produced a revolutionary breakthrough, continues today. Unfortunately, as I argue in this review, it may be that analgesia simply cannot be divorced from so-called side effects.
The fulcrum of the canonical endogenous analgesia pathway is the medullary raphe magnus
During the 1970s and early 1980s, the research of Allan Basbaum, Jean-Marie Besson, Howard Fields, John Liebeskind, Barry Sessle, Linda Watkins, and several others revealed the basic anatomy and physiology of the analgesia-producing circuitry engaged by brainstem stimulation and supraspinal opioids [4, 11] . The resulting canonical pathway involves projections from neurons in the midbrain PAG to neurons of the medullary raphe magnus, which, in turn, project to the spinal and trigeminal dorsal horn. Activation of neurons in both the PAG and raphe magnus suppresses both the responses of dorsal horn cells to noxious stimulation and nocifensive motor reactions. Fundamentally, it is important to note that this pathway descends to contact nociceptive laminae of the dorsal horn where neurons receive direct nociceptor input from the periphery. Thus, the output from raphe magnus modulates sensory input at the initial central synapses carrying nociceptive information.
Howard Fields propelled our understanding of the cellular basis of descending analgesia forward when he described the ON and OFF cell classes of the raphe magnus and proposed a basic functional circuit involving these cell types [4, 12, 13] . Not only does Fields' fundamental proposal endure in its nearly original form to this day, more importantly, the framework of ON and OFF cells has proved spectacularly heuristic over the years. Indeed, experiments aimed at selectively lesioning ON cells have revealed that this cell population within raphe magnus is necessary for the development and maintenance of certain chronic pain conditions, including the neuropathic pain that results from spinal nerve ligation [38, 39] . Thus, raphe magnus is capable of facilitating as well as suppressing nociceptive transmission. The recognition that nociceptive transmission is bi-directionally modulated by raphe magnus led to the renaming of endogenous analgesia to the more neutral term, endogenous pain modulation.
The power of Fields' model derives from the consistent finding that a cell's response to noxious stimulation predicts that cell's response to an analgesic dose of an opioid in the anesthetized rat [3] . Thus, after easily identifying ON and OFF cells characterized by their excitatory and inhibitory responses to noxious stimulation, respectively [12] , the experimenter immediately knows that ON cells will be inhibited by opioids and OFF cells excited. Using this physiological shortcut, numerous studies have led to the conclusion that ON cell firing is pronociceptive and OFF cell firing is antinociceptive. Under baseline conditions in the anesthetized rat, ON cells fire together, OFF cells fire together, and ON and OFF cells fire in alternating bursts [24] . In response to an analgesic manipulation such as morphine administration, OFF cells fire continuously and ON cells fall silent (Fig. 1A) [3, 6] . The model holds that it is the continuous discharge of OFF cells which suppresses nociceptive transmission so that ''pain'' is suppressed. Conversely, an increase in ON 
